Log in

CNC Traphaco High Tech JSC UPCOM · Vietnam

Traphaco High Tech JSC (CNC) news

Traphaco High Tech JSC is a public biotech or pharmaceutical company listed on UPCOM under the ticker CNC, recorded under Vietnam. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Traphaco High Tech JSC news

We have not published a story on Traphaco High Tech JSC yet. When there is news, it will appear here.

Questions about Traphaco High Tech JSC

What is the ticker symbol of Traphaco High Tech JSC?

Traphaco High Tech JSC trades under the ticker CNC on UPCOM.

Where is Traphaco High Tech JSC listed?

Traphaco High Tech JSC is listed on UPCOM.

Which country or territory is Traphaco High Tech JSC listed under?

Our directory records Traphaco High Tech JSC under Vietnam.

What does Traphaco High Tech JSC do?

Our directory classifies Traphaco High Tech JSC as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Traphaco High Tech JSC?

The ISIN recorded for Traphaco High Tech JSC is VN000000CNC9.

Does aibio.space cover Traphaco High Tech JSC?

aibio.space lists Traphaco High Tech JSC among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Traphaco High Tech JSC?

Companies in our directory listed in the same country and business area as Traphaco High Tech JSC: Central Pharmaceutical JSC No. 3, Traphaco Joint Stock, Viet Nam Herbs & Foods JSC, Vietnam Medicinal Materials Joint Stock, Viet Nam Pharmaceutical Corporation - Joint Stock Co, Nghe An Pharmaceutical Medical Material and Equipment Joint Stock Co.

Investor discussion: Traphaco High Tech JSC

Members talk about Traphaco High Tech JSC (CNC). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Traphaco High Tech JSC is a public biotech or pharmaceutical company listed on UPCOM under the ticker CNC, recorded under Vietnam. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Traphaco High Tech JSC
Ticker
CNC
Listing
UPCOM
Country or territory
Vietnam
Business scope
Biopharma / pharmaceutical profile checked
ISIN
VN000000CNC9
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.